MedPath

Acute Metabolic and Endocrine Responses of Glucose and Fructose in Healthy Young Subjects

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT02590913
Lead Sponsor
Zhejiang University
Brief Summary

The purpose of this study is to investigate the metabolic and endocrine responses during 3 hour after taking 75g fructose or glucose in young Chinese.

Detailed Description

The study was a double-blinded, randomized, crossover trial. Twenty healthy volunteers were randomized to two groups: group A (300ml of 22.5% glucose) and group B (300ml of 22.5% fructose).Volunteer was randomized into either group A or B, after an 8-h overnight fasting, took 300ml of solution at 0830 within 5 minutes. After one-week washout period, volunteer was crossed over for either group B or A. each intervention, venous blood was collected at 0h, 0.5h, 1h, 2h, and 3h and blood pressure was tested at 0h, 1h, 2h, and 3h.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Inclusion criteria were aged 19-39 years, with BMI between 18-24 kg/m 2.
Exclusion Criteria
  • Subjects pregnant or having a history of hepatic or renal disease, fructose intolerance, gout, hypoglycemia, or diabetes mellitus were excluded.
  • Subjects taking any drugs, botanicals, or nutraceutical known to influence blood pressure also were rejected either.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
serum uric acid3 hours

Serum uric acid concentration was analyzed on HITACHI 7020 chemistry analyzer using enzyme-based colorimetric test or colorimetric test supplied by DiaSys Diagnostic Systems (Shanghai) Co., Ltd

Secondary Outcome Measures
NameTimeMethod
blood pressure3 hours

Blood pressure was measured at Zhejiang University Hospital by the research workers who were blind to the groups within 3 hours blood collection.

Trial Locations

Locations (1)

Zhejiang university

🇨🇳

Hangzhou, Zhejiang, China

Zhejiang university
🇨🇳Hangzhou, Zhejiang, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.